As of Sep 30
| +0.009 / +0.96%|
The 1 analysts offering 12-month price forecasts for X T L Biopharmaceuticals Ltd have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +531.58% increase from the last price of 0.95.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.